livemint.com
94%
446
Covaxin: Indian Covid-19 vaccine maker says recruitment for trials on track
Also Read | Dark underbelly of India Inc’s shop floorsLocal news reports last week suggested that some of those trial sites were well short of reaching intended recruitment targets.A study at the government-run AIIMS medical institute had only signed up some 200 participants, compared with a goal of 1,500-2,000, Reuters partner ANI reported last week, citing a doctor at the institute.The shot, called COVAXIN, was evaluated in about 1,000 participants in early and mid-stage trials."We are overwhelmed with the steady rise in participation," Bharat Biotech joint Managing Director Suchitra Ella said in a statement on Tuesday.With more than 10 million infections, India, the world's biggest vaccine producing country, is also the second worst-hit